Early Markers of Subclinical Pulmonary Vascular Radiation Toxicity in Breast Cancer


Primary purposes:1. Quantify differences in extent of pulmonary vessel radiation damage in breast cancer patients receiving conventional X-ray versus proton RT using serial CT chest scans. Specifically, we will identify differences between the modalities in regards to the lower dose limits for observable vascular changes; the magnitude of effects and dose-response relationship; and the temporal patterns of recovery and vessel regeneration. 2. Quantify differences in temporal patterns of levels of cytokines in the blood in breast cancer patients receiving conventional X-ray versus proton RT using serial blood draws that are time-matched with the CT chest scans. 3.    Mathematically model the causal relationship between cytokines levels and vascular damage, and quantify differences between X-ray and proton treatment methodologies in this aspect. The secondary purposes of the study are 1. To monitor long-term (>8 year) incidence of clinical pulmonary toxicity and overall survival in these patients to identify any difference between X-ray and proton treatment methodologies. 2.    To identify patterns of asymptomatic metastatic progression in those patients who develop recurrence to the thorax during the follow-up imaging period.


Breast Cancer, Radiation Toxicity, CT chest scans, clinical pulmonary toxicity

Principal Investigator

Walter O'Dell

Sponsoring Group

Department of Radiation Oncology

Contact Information



Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams